Pathology - GoINPHARMA
Tuesday, 16 October 2018 - 19:47

Pathology

Novartis introduces therapy arsenal for multiple sclerosis

Novartis has introduced today at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), currently being held in Berlin, data related to a clinical trial assessing Gilenya (fingolimod), an oral therapy for MS, in addition…

Upsurge in cholera cases in blighted Yemen

Al Jazeera has reported that the number of cholera cases in Yemen (Hodeidah region) has tripled following the offensive by Saudi Arabian/UAE troops.  The outbreak has recently exceeded 1,300 cases, 30% of which are children, multiple sources have reported. The…

WHO report about alcohol use and alcoholism

  The World Health Organization (WHO) has published a long and detailed report about the spread and effects on society of alcohol beverages. Over 3 million people died due to excessive alcohol use in 2016 , which corresponds to 5%…

New therapies preventing migraine episodes to be launched

US-based drugmaker Eli Lilly & Co. on Friday announced that EMA has recommended the marketing approval in Europe for its monoclonal antibody Emgality (galcanezumab). Emgality has already been granted conditional approval in the US by FDA. It is part of…

Link between obesity and cognitive capacities discovered

Over the last few years, various scientific articles have tried to detect a link between obesity and cognitive capacities. The studies followed statistical observation suggesting that cognitive capacities are lower in obese babies than in non-obese ones.  A report published…

New developments of Crispr technology for potential cure to dystrophy

The prestigious journal Science has published an important article reporting the correction of a genetic mutation in four dogs with Duchenne’s disease – an extremely serious type of muscular dystrophy. The team of researchers from the UT Southwestern Medical Center…

Connectome Project aims to discover how brain develops

A team of scientists from the King’s College of London, the Imperial College and the University of Oxford has started the Developing Human Connectome Project, aimed at discovering how the brain develops during prenatal life. The researchers have developed a…

Good Phase III results for Novartis’ cancer drug (breast cancer)

Novartis has announced today that its investigational BYL719  (alpelisib) therapy has reached its primary endpoints in the Phase III Solar-1 clinical trial. BYL719 is an alpha-specific PI3K inhibitor developed for the treatment of PIK3CA-mutant breast cancer, tested as intravenous infusion…

Wheat genome, among the most complex in nature, now decoded

The journal Science Advances has published on its latest issue an article by a team of Australian researchers led by Angela Juhasenz, reporting the decoding of wheat genome, one of the most complex genomes found in nature. The results will…

GSK announces new positive clinical data for two-drug HIV treatment

ViiV Healthcare, a subsidiary of  GlaxoSmithKline’s focusing on HIV, has reported today, before trading started in Europe, results from the Phase III Atlas clinical trial, enrolling 618 patients with HIV, treated with a cabotegravir-rilpivirine injected treatment for 48 weeks. The…

Biotech BeiGene ready for listing in Hong Kong

China-based biotech BeiGene, listed in the US Nasdaq, has announced it pursues a listing in the Hong Kong stock market too. According to BeiGene’s management, this second listing should fetch the company at least $903m. The biotech will offer 65…

Worrisome rise in malaria cases: 700,000 victims per year now

The scientific journal Nature has published a long and detailed review about the dramatic increase of malaria cases in the poorest areas of the world, where it is the first cause of death, killing 450,000-700,000 people annually. The most efficient…

New Ebola outbreak seems contained

Good news about Ebola: the World Health Organization has informed that the new outbreak reported in the Democratic Republic of Congo–and specifically in the densely populated city of Mbandaka–seems to have been contained. Since April 1st, physicians have reported as…

NASH sector heats up

Bloomberg yesterday reported that biotech Madrigal Pharmaceuticals  is weighing a sale after some early talks with large pharmaceutical groups. The news has made Madrigal’s shares jump by over 150% in the last month. Madrigal is a biotech based in Pennsylvania,…

Worrisome increase in spread of sexually-transmitted diseases

The spreading rate of sexually-transmitted diseases is worrisomely increasing in the UK. The most recent data demonstrate that syphilis cases have risen by 20% over the last year, while gonorrhea cases by 22%, and experts are particularly worried by a…

Inflammation triggers depression

Depression is nowadays one of the most widespread diseases in the world. Although millions of people suffer from it, its real causes are still unknown. Neuropsychiatrist Edward Bullmore, from the University of Cambridge (UK) has proposed that depression is a…

Brain’s role in diabetes: new approach to insulin regulation

The prestigious journal Science has published today a significant study by a team of scientists led by Kasper Horst, from the Department of Endocrinology and Metabolism, Academic Medical Center of Amsterdam. The study reports data showing the brain’s role in…

Revolutionary theory explaining origin of childhood leukemia

The English scientist Mel Greaves, from the Institute of Cancer Research of London, has formulated an original theory about the onset of childhood leukemia, which has been published in the latest issue of Nature Review Cancer. According to Graves, leukemia…